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Background
In hydrocephalus, interruptions in normal CSF flow path-
ways create a deficiency in the ability of the CSF to clear
toxic substances from the brain. One important substance
known to be affected by impaired clearance is amyloid-β
(Aβ). The accumulation of Aβ causes dementia commonly
found in patients with normal pressure hydrocephalus
(NPH) and Alzheimer's diseased (AD) due to deficiencies
in Aβ transport proteins: low density lipoprotein receptor-
related protein-1 (LRP-1) and receptor for advanced glyca-
tion end products (RAGE). Although the prevalence of
neonatal hydrocephalus is relatively high, no studies have
examined protein clearance mechanisms in children with
hydrocephalus or immature experimental animals with
this disorder. We hypothesized that impaired clearance of
Aβ occurs in the neonatal hydrocephalic brain and is
accompanied by alterations in Aβ transporters. Addition-
ally, studies have shown a correlation between astrocytes
and Aβ in cases of NPH and AD. Because astrocytes help
maintain the blood-brain barrier and therefore may be
involved in Aβ clearance, we speculated that there would
be an association between Aβ and astrocytes with the pro-
gression of hydrocephalus.
Materials and methods
Rats received intracisternal kaolin injections on post-natal
day one and developed severe ventriculomegaly over a
three-week period. Age-matched control animals were
included for comparison. MRI was performed to confirm
or rule out ventriculomegaly. Animals were sacrificed on
day 21 and tissue was processed for immunohistochemis-
try to visualize cellular morphology and the presence of
LRP-1, RAGE, Aβ, and GFAP. Adult hydrocephalic tissue
was also analyzed for a positive control. Additional ani-
mals were sacrificed at day 21 and fresh tissue was taken
for quantitative real time RT PCR.
Results
The amount of labelling for Aβ, RAGE, and LRP-1 was
reduced in 21 day hydrocephalic animals in the cortex
and hippocampus compared to adult hydrocephalic ani-
mals. Comparing 21 day hydrocephalic to 21-day saline
control animals, no change was detected in Aβ, RAGE, and
LRP-1 in the cortex, hippocampus and choroid plexus.
The labelling of GFAP in the 21 day hydrocephalic group
was dramatically elevated in the cerebral cortex and hip-
pocampus.
Conclusion
Minimal expression of the transporter proteins could have
been due to immature clearance mechanisms in young
animals, or the severity of hydrocephalus could have
caused decrease blood flow leading to a deficiency in
transporters.
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